Advent Pharma Ltd.

ADVENT

BD0492ADVPL9

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 18:00:00 2024-06-29 EDT			5-day change	1st Jan Change
25.6 ^BDT	-1.16%		+2.81%	+2.81%

04-29	Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-06	Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Advent Pharma Ltd. Announces Approval to Introduce New Products

February 04, 2020 at 10:04 am

Advent Pharma Ltd. has informed that they have got approval to introduce 11 (Eleven) new products from Directorate General of Drug Administration, where new therapeutic class of 6 Injectables, along with 4 liquid items and 1 bolus item.

Latest news about Advent Pharma Ltd.

Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	04-28	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-05	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-13	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2023	23-10-29	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-12	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-23	CI
Advent Pharma Ltd. Completes Signing Agreement of Distributorship with Alltech Biotechnology Pvt Ltd	22-11-17	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended June 30, 2022	22-10-30	CI
Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-24	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-01-29	CI
Advent Pharma Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-12-01	CI
Advent Pharma Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2021	21-10-31	CI
Advent Pharma Ltd. Appoints Asif Iqbal Chowdhury as Chairman	21-05-06	CI
21,567,500 Ordinary Shares of Advent Pharma Limited are subject to a Lock-Up Agreement Ending on 12-APR-2021.	21-04-11	CI
Advent Pharma Ltd. Appoints Faria Binte Alam as the Managing Director	20-07-02	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	20-03-24	CI
Advent Pharma Ltd. Announces Approval to Introduce New Products	20-02-04	CI
Advent Pharma Ltd. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-01-29	CI
Advent Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	19-10-29	CI
Advent Pharma Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	19-04-28	CI
27,032,500 Ordinary Shares of Advent Pharma Limited are subject to a Lock-Up Agreement Ending on 12-APR-2019.	19-04-11	CI
Advent Pharma Limited Announces Change of Head Office	19-04-02	CI
Advent Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018	19-01-29	CI
Advent Pharma Limited Recommends Cash Dividend for the Year Ended June 30, 2018	18-10-21	CI

Chart Advent Pharma Ltd.

Duration

Period

More charts

Company Profile

Advent Pharma Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing, importing and marketing of animal health care drugs, nutritional supplements and feed additives for livestock like powder, bolus and liquid dosage forms. Its product category includes aquaculture, cattle, and poultry. Its aquaculture products include GRO-PLUS, Oxi-D Bolus, and RUMIGEST HP. Its cattle products include ABC Solution, ACIPURE PLUS, AD-HISTA Vet Injection, ADBOVI Powder, ADCAL-P, ADCET BOLUS, ADCIPCIN, ADCIPCINE BOLUS, ADLYTE, ADPROLIM PLUS POWDER and ADRIZOL Bolus. Its poultry products include ADSULPH Bolus, ADVIT B COMPLEX, ADVIT C, ADVIT CP, ADVIT CP PLUS Bolus, ADVIT DB Powder, ADVIT E-SEL, ADVIT-D PLUS Solution, ADVOMICA, ADZURIL, ADZYL Bolus, ADZYME LIQUID, ADZYME POWDER, COUGH OFF, EGG BOOST, FERON VET, Liver On, MASTIVIT, NEO SUPER VET, NEPHROSOL, TOXOSORB, TILFOS VET, NUTARIN, and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

	1st Jan change	Capi.
ADVENT PHARMA LTD.	+2.81%	20.27M
ZOETIS INC.	-11.65%	78.75B
ELANCO ANIMAL HEALTH INCORPORATED	-6.41%	6.97B
BLUESTAR ADISSEO COMPANY	+22.12%	3.7B
VIRBAC	-6.12%	3.03B
VIMIAN GROUP AB	+12.67%	1.66B
JINYU BIO-TECHNOLOGY CO., LTD.	-33.80%	1.12B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-36.68%	1.07B
WUHAN KEQIAN BIOLOGY CO.,LTD	-31.31%	931M
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-14.58%	891M